CLINICAL_TRIALS
trial_result
· 2023-09-13
Clinical Trial Update: A Study of LY3437943 in Participants Who Have Obesity or Are Overweight [Phase 2]
Summary
Phase 2 trial update for LY3437943 in participants with obesity or who are overweight; study completed with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 2 | Status: COMPLETED | Results posted: 2023-09-13